Other RYR1 mutations render the RyR1 channel hypersensitive to triggering agents in volatile anesthetics and induce excessive Ca2+ release from the SR, resulting in malignant hyperthermia (MH) [50,51]. The gene discussed is RYR1; the disease is Malignant hyperthermia.